Post-transplant cyclophosphamide demonstrates lower non-relapse mortality and better graft-versus-host disease/relapse-free survival compared with antithymocyte globulin in unrelated donor hematopoietic stem cell transplantation. A single-center experience.
Bone Marrow Transplant
; 56(4): 986-988, 2021 04.
Article
em En
| MEDLINE
| ID: mdl-33249426
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Transplante de Células-Tronco Hematopoéticas
/
Doença Enxerto-Hospedeiro
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article